Role of 18FDG-positron emission tomography scanning in the management of histiocytosis.
Diagnostic evaluation of histiocytic malignancies often involves a range of imaging studies to characterize skeletal and extraskeletal sites of involvement. Functional imaging with 18FDG PET provides a potential method for non-invasively detecting active disease. We report two cases where this modality was positive and facilitated therapeutic monitoring.
Blum
Robert
R
Division of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, Locked Bag 1, A' Beckett Street, East Melbourne, Victoria, 8006 Australia. blumrobert@petermac.unimelb.edu.au
Seymour
John F
JF
Hicks
Rod J
RJ
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy; D019468:Disease Management; D019788:Fluorodeoxyglucose F18; D015614:Histiocytosis / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000188:drug therapy; D006646:Histiocytosis, Langerhans-Cell / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy; D006801:Humans; D008297:Male; D009367:Neoplasm Staging / Q000379:methods; D014055:Tomography, Emission-Computed; D016896:Treatment Outcome
D019788:Fluorodeoxyglucose F18